Equity Overview
Price & Market Data
Price: $2.44
Daily Change: -$0.17 / 6.97%
Daily Range: $2.44 - $2.50
Market Cap: $10,729,939,968
Daily Volume: 200
Performance Metrics
1 Week: -6.51%
1 Month: -12.23%
3 Months: -26.06%
6 Months: -14.39%
1 Year: 21.39%
YTD: -12.23%
Company Details
Employees: 40557
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. manufactures, distributes, and sells pharmaceutical products in Mainland China and internationally. The company offers pharmaceutical products for anti-tumor and immune modulation, metabolism and alimentary system, anti-infection, central nervous system, and cardiovascular system; and APIs and intermediates, including amino acid, tranexamic acid, levamisole hydrochloride, and clindamycin hydrochloride. It also provides mRNA vaccines for Covid-19; medical devices for medical cosmetology respiratory health and professional medical products; oncology, neuroscience and other specialty fields; and solutions for infections, tumors, the central nervous system, and chronic diseases. In addition, the company offers online and offline medical services, such as pharmaceuticals and medical devices, consumer healthcare and special commodities; specialized medical disciplines; and insurance services. Further, it is involved in the import and export of medical equipment and the provision of related and other consulting services and investment management. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.